Does TOFACITINIB Cause Hypersensitivity? 6,172 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6,172 reports of Hypersensitivity have been filed in association with TOFACITINIB (XELJANZ XR). This represents 4.0% of all adverse event reports for TOFACITINIB.
6,172
Reports of Hypersensitivity with TOFACITINIB
4.0%
of all TOFACITINIB reports
1,409
Deaths
2,286
Hospitalizations
How Dangerous Is Hypersensitivity From TOFACITINIB?
Of the 6,172 reports, 1,409 (22.8%) resulted in death, 2,286 (37.0%) required hospitalization, and 1,711 (27.7%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which TOFACITINIB Alternatives Have Lower Hypersensitivity Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN